IDO1 and COVID-19: Interestingly, the Th2 anti-inflammatory cytokine—IL-4, which is released during COVID-19 cytokine storm, in addition to its ability to activate astrocytes, appears to have the ability to potentiate IFN-γ-mediated microglial IDO activation [181].